Trump Admin Cuts Funding for Research Using Aborted Fetal Tissue
The Department of Health and Human Services (HHS) has decided to end its contract between Advanced Bioscience Resources and the FDA that used fetal tissue from elective abortions to develop testing protocols.
In a statement, DHS said:
The Department was not sufficiently assured that contract included the appropriate protections applicable to fetal tissue research or met all other procurement requirements. As a result, HHS also initiated a comprehensive review of all HHS research involving human fetal tissue from elective abortions to ensure consistency with statutes and regulations governing such research, and to ensure the adequacy of procedures and oversight of this research in light of the serious regulatory, moral, and ethical considerations involved.
Pro-life groups have cheered the Trump Administration’s decision, with Marjorie Jones Dannenfelser, president of the Susan B. Anthony list saying, “This is major pro-life victory and we thank President Trump for decisive action. It is outrageous and disgusting that we have been complicit, through our taxpayer dollars, in the experimentation using baby body parts.”
Jeanne Mancini, the president of March for Life, said in a statement, “March for Life applauds the Administration for halting funding for research that requires aborted fetal organs and tissue. Most Americans do not want their tax dollars creating a marketplace for aborted baby body parts which are then implanted into mice and used for experimentation. This type of research involves the gross violation of basic human rights and certainly the government has no business funding it.”